Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


IGEN places 1 million shares:

This article was originally published in Clinica

Executive Summary

Gathersburg, Maryland-based IGEN has placed slightly over 1 million shares with two investment arms from the Acqua Wellington group. The transaction has raised $30 million. It will enable IGEN to continue advancing its business plan and to help fund the cost of legal proceedings against Roche. IGEN is locked in patent litigation with the Swiss worldwide diagnostics market leader over distribution rights to its ORIGEN technology. Last month, IGEN secured victory in Delaware (see Clinica No 986, p 17), but the larger Maryland case is still pending.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts